Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Peter Jan Zimmermann is active.

Publication


Featured researches published by Peter Jan Zimmermann.


Tetrahedron Letters | 1986

Synthesis of D-erythro-sphingosines

Richard R. Schmidt; Peter Jan Zimmermann

Abstract 2,4-Di-O-protected D-threose, readily available from D-galactose, is a versatile intermediate for D-erythro-ephingosine syntheses via trans-selective Wittig reaction, azide introduction at the unprotected hydroxylic group, and subsequent azide reduction.


Journal of Medicinal Chemistry | 2010

Tetrahydrochromenoimidazoles as Potassium-Competitive Acid Blockers (P-CABs): Structure—Activity Relationship of Their Antisecretory Properties and Their Affinity toward the hERG Channel

Andreas Palmer; Vittoria Chiesa; Anja Schmid; Gabriela Münch; Burkhard Grobbel; Peter Jan Zimmermann; Christof Brehm; Wilm Buhr; Wolfgang-Alexander Simon; Wolfgang Kromer; Stefan Postius; Jürgen Volz; Dietmar Hess

Potassium-competitive acid blockers (P-CABs) constitute a new therapeutic option for the treatment of acid-related diseases that are widespread and constitute a significant economical burden. Enantiomerically pure tetrahydrochromenoimidazoles were prepared using the readily available candidate 4 (BYK 405879) as starting material or the Noyori asymmetric reduction of ketones as key reaction. A comprehensive SAR regarding the influence of the 5-carboxamide and the 8-aryl residue on in vitro activity, acid-suppression in the Ghosh Schild rat, and affinity toward the hERG channel was established. In addition, efficacy and duration of the antisecretory action was examined for the most promising target compounds by 24 h pH-metry in the fistula dog and a significantly different SAR was observed as compared to the Ghosh Schild rat. Several tetrahydrochromenoimidazoles were identified that possessed a comparable profile as the candidate 4.


Journal of Medicinal Chemistry | 2007

Synthesis and evaluation of 7H-8,9-dihydropyrano[2,3-c]imidazo[1,2-a]pyridines as potassium-competitive acid blockers.

Andreas Palmer; Burkhard Grobbel; Cornelia Jecke; Christof Brehm; Peter Jan Zimmermann; Wilm Buhr; Martin Feth; Wolfgang-Alexander Simon; Wolfgang Kromer


Archive | 2003

4-substituted benzimidazoles and their use as inhibitors of gastric secretion

Wilm Buhr; Peter Jan Zimmermann; Vittoria Chiesa; Andreas Palmer; Christof Brehm; Gerhard Grundler; Joerg Senn-Bilfinger; Wolfgang-Alexander Simon; Stefan Postius; Wolfgang Kromer


Archive | 2001

POLYSUBSTITUTED IMIDAZOPYRIDINES AS GASTRIC SECRETION INHIBITORS

Jörg Senn-Bilfinger; Wilm Buhr; Peter Jan Zimmermann; Bernhard Kohl


Tetrahedron Letters | 2006

Glucuronide conjugates of Soraprazan (BY359), a new potassium-competitive acid blocker (P-CAB) for the treatment of acid-related diseases

Jörg Senn-Bilfinger; John R. Ferguson; Michael A. Holmes; Keith W. Lumbard; Reinhard Huber; Karl Zech; Rolf-Peter Hummel; Peter Jan Zimmermann


Archive | 2003

8-Substituted imidazopyridines

Wilm Buhr; Joerg Senn-Bilfinger; Peter Jan Zimmermann


Archive | 2004

Tricyclic imidazopyridines for use as gastric secretion inhibitors

Christof Brehm; Wilm Buhr; M. Vittoria Chiesa; Wolfgang Kromer; Andreas Palmer; Stefan Postius; Wolfgang-Alexander Simon; Peter Jan Zimmermann


Archive | 2005

1,2,4-triazolo[1,5-a] pyridines as gastric acid secretion inhibitors

Wilm Buhr; Peter Jan Zimmermann; Christof Brehm; Andreas Palmer; M. Vittoria Chiesa; Wolfgang-Alexander Simon; Stefan Postius; Wolfgang Kromer


Archive | 2005

7-substituted benzimidazoles and their use as inhibitors of gastric acid secretion

Peter Jan Zimmermann; Wilm Buhr; M. Vittoria Chiesa; Andreas Palmer; Christof Brehm; Wolfgang-Alexander Simon; Stefan Postius; Wolfgang Kromer

Collaboration


Dive into the Peter Jan Zimmermann's collaboration.

Researchain Logo
Decentralizing Knowledge